(UDR) UDR - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US9026531049
Stock: Apartment Homes, Multifamily Properties, Real Estate
Total Rating 34
Risk 31
Buy Signal -0.57
| Risk 5d forecast | |
|---|---|
| Volatility | 23.7% |
| Relative Tail Risk | 0.83% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.49 |
| Alpha | -18.85 |
| Character TTM | |
|---|---|
| Beta | 0.610 |
| Beta Downside | 0.809 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.80% |
| CAGR/Max DD | -0.04 |
EPS (Earnings per Share)
Revenue
Description: UDR UDR January 03, 2026
UDR, Inc. (NYSE: UDR) is an S&P 500-listed multifamily REIT that owns or holds an interest in roughly 60,500 apartment units across the United States, with about 300 units currently under development (as of 30 Sept 2025). The company’s business model centers on acquiring, redeveloping, and managing residential communities to generate stable cash flows and long-term shareholder value.
Key quantitative points (FY 2024 – public filings) that complement the description are: (1) occupancy averaged ≈ 95 % across its portfolio, supporting a relatively high and predictable revenue base; (2) funds-from-operations (FFO) grew ≈ 4 % year-over-year to $1.02 per share, indicating modest earnings momentum; and (3) average rent growth in its core markets ran about 3.8 % YoY, outpacing the national CPI inflation rate of 3.3 % for the same period. The sector’s outlook is heavily influenced by demographic trends (e.g., millennial migration to Sun Belt metros) and the supply-side constraint of new multifamily construction, while rising interest rates pose a refinancing risk that could compress yields.
For a deeper quantitative view, you might explore ValueRay’s detailed valuation metrics for UDR.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 377.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -1.51 > 1.0 |
| NWC/Revenue: 6.16% < 20% (prev -26.52%; Δ 32.69% < -1%) |
| CFO/TA 0.15 > 3% & CFO 1.54b > Net Income 377.7m |
| Net Debt (6.15b) to EBITDA (1.03b): 5.98 < 3 |
| Current Ratio: 3.31 > 1.5 & < 3 |
| Outstanding Shares: last quarter (332.6m) vs 12m ago 0.42% < -2% |
| Gross Margin: 37.35% > 18% (prev 0.25%; Δ 3710 % > 0.5%) |
| Asset Turnover: 15.93% > 50% (prev 15.34%; Δ 0.58% > 0%) |
| Interest Coverage Ratio: 2.37 > 6 (EBITDA TTM 1.03b / Interest Expense TTM 146.9m) |
Altman Z'' -1.70
| A: 0.01 (Total Current Assets 151.2m - Total Current Liabilities 45.6m) / Total Assets 10.61b |
| B: -0.40 (Retained Earnings -4.24b / Total Assets 10.61b) |
| C: 0.03 (EBIT TTM 348.5m / Avg Total Assets 10.75b) |
| D: -0.65 (Book Value of Equity -4.19b / Total Liabilities 6.46b) |
| Altman-Z'' Score: -1.70 = D |
Beneish M -3.75
| DSRI: 0.59 (Receivables 150.0m/247.8m, Revenue 1.71b/1.67b) |
| GMI: 0.67 (GM 37.35% / 24.94%) |
| AQI: 1.01 (AQ_t 0.97 / AQ_t-1 0.96) |
| SGI: 1.02 (Revenue 1.71b / 1.67b) |
| TATA: -0.11 (NI 377.7m - CFO 1.54b) / TA 10.61b) |
| Beneish M-Score: -3.75 (Cap -4..+1) = AAA |
What is the price of UDR shares?
As of February 23, 2026, the stock is trading at USD 37.17 with a total of 3,945,760 shares traded.
Over the past week, the price has changed by -2.18%, over one month by -1.01%, over three months by +5.55% and over the past year by -9.99%.
Over the past week, the price has changed by -2.18%, over one month by -1.01%, over three months by +5.55% and over the past year by -9.99%.
Is UDR a buy, sell or hold?
UDR has received a consensus analysts rating of 3.57.
Therefor, it is recommend to hold UDR.
- StrongBuy: 5
- Buy: 4
- Hold: 13
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the UDR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 40.9 | 10.1% |
| Analysts Target Price | 40.9 | 10.1% |
UDR Fundamental Data Overview February 22, 2026
P/E Trailing = 32.8938
P/E Forward = 58.4795
P/S = 8.0016
P/B = 3.853
P/EG = -4.53
Revenue TTM = 1.71b USD
EBIT TTM = 348.5m USD
EBITDA TTM = 1.03b USD
Long Term Debt = 5.82b USD (from longTermDebt, last quarter)
Short Term Debt = 801.7m USD (from shortTermDebt, last quarter)
Debt = 6.19b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.15b USD (from netDebt column, last quarter)
Enterprise Value = 20.18b USD (13.99b + Debt 6.19b - CCE 1.22m)
Interest Coverage Ratio = 2.37 (Ebit TTM 348.5m / Interest Expense TTM 146.9m)
EV/FCF = 47.11x (Enterprise Value 20.18b / FCF TTM 428.3m)
FCF Yield = 2.12% (FCF TTM 428.3m / Enterprise Value 20.18b)
FCF Margin = 25.01% (FCF TTM 428.3m / Revenue TTM 1.71b)
Net Margin = 22.06% (Net Income TTM 377.7m / Revenue TTM 1.71b)
Gross Margin = 37.35% ((Revenue TTM 1.71b - Cost of Revenue TTM 1.07b) / Revenue TTM)
Gross Margin QoQ = 26.98% (prev 68.24%)
Tobins Q-Ratio = 1.90 (Enterprise Value 20.18b / Total Assets 10.61b)
Interest Expense / Debt = 0.82% (Interest Expense 50.6m / Debt 6.19b)
Taxrate = 0.02% (37.0k / 238.3m)
NOPAT = 348.5m (EBIT 348.5m * (1 - 0.02%))
Current Ratio = 3.31 (Total Current Assets 151.2m / Total Current Liabilities 45.6m)
Debt / Equity = 1.88 (Debt 6.19b / totalStockholderEquity, last quarter 3.29b)
Debt / EBITDA = 5.98 (Net Debt 6.15b / EBITDA 1.03b)
Debt / FCF = 14.36 (Net Debt 6.15b / FCF TTM 428.3m)
Total Stockholder Equity = 3.30b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.51% (Net Income 377.7m / Total Assets 10.61b)
RoE = 11.43% (Net Income TTM 377.7m / Total Stockholder Equity 3.30b)
RoCE = 3.82% (EBIT 348.5m / Capital Employed (Equity 3.30b + L.T.Debt 5.82b))
RoIC = 3.84% (NOPAT 348.5m / Invested Capital 9.07b)
WACC = 5.91% (E(13.99b)/V(20.18b) * Re(8.16%) + D(6.19b)/V(20.18b) * Rd(0.82%) * (1-Tc(0.00)))
Discount Rate = 8.16% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.58%
[DCF Debug] Terminal Value 86.94% ; FCFF base≈499.1m ; Y1≈533.7m ; Y5≈646.2m
Fair Price DCF = 39.37 (EV 19.08b - Net Debt 6.15b = Equity 12.93b / Shares 328.3m; r=5.91% [WACC]; 5y FCF grow 7.76% → 2.90% )
EPS Correlation: 37.36 | EPS CAGR: 112.0% | SUE: 4.0 | # QB: 1
Revenue Correlation: 91.01 | Revenue CAGR: 5.27% | SUE: 3.64 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.13 | Chg30d=+0.005 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-12-31): EPS=0.42 | Chg30d=-0.176 | Revisions Net=-3 | Growth EPS=-62.5% | Growth Revenue=+1.3%
EPS next Year (2027-12-31): EPS=0.54 | Chg30d=-0.160 | Revisions Net=-2 | Growth EPS=+26.3% | Growth Revenue=+3.4%
P/E Forward = 58.4795
P/S = 8.0016
P/B = 3.853
P/EG = -4.53
Revenue TTM = 1.71b USD
EBIT TTM = 348.5m USD
EBITDA TTM = 1.03b USD
Long Term Debt = 5.82b USD (from longTermDebt, last quarter)
Short Term Debt = 801.7m USD (from shortTermDebt, last quarter)
Debt = 6.19b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.15b USD (from netDebt column, last quarter)
Enterprise Value = 20.18b USD (13.99b + Debt 6.19b - CCE 1.22m)
Interest Coverage Ratio = 2.37 (Ebit TTM 348.5m / Interest Expense TTM 146.9m)
EV/FCF = 47.11x (Enterprise Value 20.18b / FCF TTM 428.3m)
FCF Yield = 2.12% (FCF TTM 428.3m / Enterprise Value 20.18b)
FCF Margin = 25.01% (FCF TTM 428.3m / Revenue TTM 1.71b)
Net Margin = 22.06% (Net Income TTM 377.7m / Revenue TTM 1.71b)
Gross Margin = 37.35% ((Revenue TTM 1.71b - Cost of Revenue TTM 1.07b) / Revenue TTM)
Gross Margin QoQ = 26.98% (prev 68.24%)
Tobins Q-Ratio = 1.90 (Enterprise Value 20.18b / Total Assets 10.61b)
Interest Expense / Debt = 0.82% (Interest Expense 50.6m / Debt 6.19b)
Taxrate = 0.02% (37.0k / 238.3m)
NOPAT = 348.5m (EBIT 348.5m * (1 - 0.02%))
Current Ratio = 3.31 (Total Current Assets 151.2m / Total Current Liabilities 45.6m)
Debt / Equity = 1.88 (Debt 6.19b / totalStockholderEquity, last quarter 3.29b)
Debt / EBITDA = 5.98 (Net Debt 6.15b / EBITDA 1.03b)
Debt / FCF = 14.36 (Net Debt 6.15b / FCF TTM 428.3m)
Total Stockholder Equity = 3.30b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.51% (Net Income 377.7m / Total Assets 10.61b)
RoE = 11.43% (Net Income TTM 377.7m / Total Stockholder Equity 3.30b)
RoCE = 3.82% (EBIT 348.5m / Capital Employed (Equity 3.30b + L.T.Debt 5.82b))
RoIC = 3.84% (NOPAT 348.5m / Invested Capital 9.07b)
WACC = 5.91% (E(13.99b)/V(20.18b) * Re(8.16%) + D(6.19b)/V(20.18b) * Rd(0.82%) * (1-Tc(0.00)))
Discount Rate = 8.16% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.58%
[DCF Debug] Terminal Value 86.94% ; FCFF base≈499.1m ; Y1≈533.7m ; Y5≈646.2m
Fair Price DCF = 39.37 (EV 19.08b - Net Debt 6.15b = Equity 12.93b / Shares 328.3m; r=5.91% [WACC]; 5y FCF grow 7.76% → 2.90% )
EPS Correlation: 37.36 | EPS CAGR: 112.0% | SUE: 4.0 | # QB: 1
Revenue Correlation: 91.01 | Revenue CAGR: 5.27% | SUE: 3.64 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.13 | Chg30d=+0.005 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-12-31): EPS=0.42 | Chg30d=-0.176 | Revisions Net=-3 | Growth EPS=-62.5% | Growth Revenue=+1.3%
EPS next Year (2027-12-31): EPS=0.54 | Chg30d=-0.160 | Revisions Net=-2 | Growth EPS=+26.3% | Growth Revenue=+3.4%